None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged 20 to 40 years 2. Subjects with a facial Global Acne Grading System (GAGS) score of 1 to 30 3. Subjects who understood the purpose and content of the study and voluntarily signed the informed consent form 4. Subjects without acute or chronic physical diseases, including skin diseases 5. Subjects who were able to comply with follow-up visits during the study period
Exclusion criteria
Exclusion criteria: 1. Subjects who did not wish to participate or did not sign the informed consent form 2. Subjects who were pregnant, lactating, or planning pregnancy within 6 months 3. Subjects who had used topical steroid-containing preparations for the treatment of skin diseases for more than 1 month 4. Subjects with sensitive or hypersensitive skin 5. Subjects with abnormal skin findings at the test site, such as moles, acne, erythema, or telangiectasia 6. Subjects who had used products with the same or similar efficacy on the test site within 3 months before the study 7. Subjects who had undergone procedures on the test site within 6 months before the study 8. Subjects with mental illness or intellectual disability 9. Subjects judged by the investigator or study staff to be unsuitable for participation in the study for any other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in follicular/comedone ratio before and after application | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of adverse skin reactions | — |
Countries
Korea, Republic of
Contacts
SKINMED